Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 238.4M | 100.0M | 2.7M | 17.6M |
Cost of revenue | 194.4M | 91.2M | 974K | 10.0M |
Gross profit | 44.0M | 8.8M | 1.8M | 7.6M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | 309K |
Other operating expenses | 4.1M | 591K | 97K | 6.0M |
Operating income | 39.4M | 8.1M | 1.7M | 1.1M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | 0 | 0 | 0 |
Other income expense | — | — | — | — |
Pretax income | 39.4M | 10.2M | 1.7M | 1.0M |
Tax provision | 0 | 0 | 0 | 0 |
Net income | 39.4M | 10.2M | 1.7M | 1.0M |
Basic EPS | — | 0.1 | 0.0 | — |
Diluted EPS | — | 0.1 | 0.0 | — |
Basic average shares | — | 120.4M | 128.4M | — |
Diluted average shares | — | 120.4M | 128.4M | — |
EBITDA | 37.4M | 10.2M | 1.7M | 1.1M |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |